{
    "nct_id": "NCT03559556",
    "official_title": "Validation Study of Treating Arteriovenous Malformation With Stereotactic Radiosurgery Using CT Angiography for Treatment Planning",
    "inclusion_criteria": "1. Documented AVM with draining vein(s).\n2. Adequate renal function (serum Creatinine < 1.5 mg/dl within 30 days of SRS) to undergo contrast CT and interventional cerebral arteriography on the same day, as determined by treating physicians.\n3. AVM must be physically separated from the optic pathway, brainstem or spinal cord.\n4. The maximum diameter of AVM nidus must be less than 3.5 cm and/or less than 12 cc.\n5. Age â‰¥ 10 years.\n6. All men, as well as women of child-bearing potential must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry and for the duration of study participation. Should a woman become pregnant or suspect she is pregnant while participating in this study, she should inform her treating physician immediately\n\n   6.1 A female of child-bearing potential is any woman (regardless of sexual orientation, having undergone a tubal ligation, or remaining celibate by choice) who meets the following criteria:\n   * Has not undergone a hysterectomy or bilateral oophorectomy; or\n   * Has not been naturally postmenopausal for at least 12 consecutive months (i.e., has had menses at any time in the preceding 12 consecutive months).\n7. Ability to understand and the willingness to sign a written informed consent.\nHealthy volunteers allowed\nMust have minimum age of 10 Years\nMust have maximum age of 120 Years",
    "exclusion_criteria": "1. Patients without a documented AVM.\n2. Patients with a contraindication to CT or MRI such as contrast allergy, kidney failure or implanted metal devices or foreign bodies or severe claustrophobia.\n3. Use of Nephrotoxic drugs, such as gentamycin, high-dose nonsteroidal anti-inflammatory drugs, or certain chemotherapeutic drugs within 10 days of the procedure.\n4. Psychiatric illness/social situations that would limit compliance with study requirements.\n5. Patients must not be pregnant at the time of SRS treatment.",
    "miscellaneous_criteria": ""
}